Isoxazole-thiazole derivatives as gaba a receptor inverse...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/06 (2006.01) A61K 31/425 (2006.01) A61K 31/4439 (2006.01) A61P 25/28 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2759598

The present invention is concerned with isoxazole-thiazole derivatives of formula I, having affinity and selectivity for GABA A a5 receptor, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful as cognitive enhancer or for the therapeutic and/or prophylactic treatment of cognitive disorders like Alzheimer's disease.

L'invention concerne des dérivés d'isoxazole-thiazole représentés par la formule I, qui présentent une affinité et une sélectivité pour le récepteur GABA A a5, un procédé de fabrication de ces dérivés, des compositions pharmaceutiques contenant ceux-ci et l'utilisation de ces dérivés comme matières thérapeutiquement actives. Les composés actifs de l'invention sont utiles comme agents améliorant les facultés cognitives ou dans le traitement thérapeutique et/ou prophylactique de troubles cognitifs tels que la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isoxazole-thiazole derivatives as gaba a receptor inverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoxazole-thiazole derivatives as gaba a receptor inverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazole-thiazole derivatives as gaba a receptor inverse... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1438058

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.